Monday, March 13, 2023
10:09 AM EST – ProMIS Neurosciences Inc : Announced an oral presentation and two onsite poster presentations at the upcoming American Academy of Neurology Annual Meeting, which will be held on April 22-27, 2023 in Boston, MA. The presentations highlight ProMIS’ broad pipeline of next-generation neurodegenerative disease therapeutics, including data that further characterize lead drug AD candidate, PMN310, as well as preclinical optimization studies of an Alzheimer’s vaccine and data supporting RACK1 as a potential target in amyotrophic lateral sclerosis (ALS). ProMIS Neurosciences Inc (T.PMN) shares were -$0.15 at 6.3.
Stocks in Play: ProMIS Neurosciences Inc, Mon, 13 Mar 2023 10:12:07 EST